Issoire Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2012
NCT01602185
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

CH Issoire | Dr Mohamed El Ayadi, Pain Clinic, Issoire Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

furosemide (lasix) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

Drugs in Phase 2 Trials (2)

dextromethorphan (delsym) (1 trial)

memantine (namenda) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 4)

Neuralgia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4